FDA Approves First Biosimilar Drug for Cancer

Mvasi (bevacizumab - awwb) is biosimilar to Avastin
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gastroenterology, Gynecology, Internal Medicine, Nephrology, Oncology, Pharmacy, Pulmonology, Institutional, Source Type: news